AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas – Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology.
See below for the Latest AstraZeneca News, Analysis, Profit Results, Share Price Information, and Commentary.
AstraZeneca unveils new R&D centre in Hong Kong
AstraZeneca unveils new R&D centre in Hong Kong
The R&D centre will focus on cell and gene therapy studies.
AstraZeneca HK, Lippo Healthcare partner for health innovation in GBA
The collaboration will address healthcare challenges in treating chronic diseases.
Commentary
The strategic decarbonisation model for Hong Kong real estate
The survival playbook for the CEO amidst geopolitical conflicts
The succession shift: Redesigning wealth structures for the next generation
2026 biotech playbook: Hong Kong at the centre of China’s globalisation